Medical Developments International Limited

CHIA:MVP Stock Report

Market Cap: AU$47.9m

Medical Developments International Management

Management criteria checks 2/4

Medical Developments International's CEO is Brent MacGregor, appointed in Nov 2020, has a tenure of 4.17 years. total yearly compensation is A$6.17M, comprised of 9.8% salary and 90.2% bonuses, including company stock and options. directly owns 0.2% of the company’s shares, worth A$96.22K. The average tenure of the management team and the board of directors is 4.3 years and 4.3 years respectively.

Key information

Brent MacGregor

Chief executive officer

AU$6.2m

Total compensation

CEO salary percentage9.8%
CEO tenure4.2yrs
CEO ownership0.2%
Management average tenure4.3yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Brent MacGregor's remuneration changed compared to Medical Developments International's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$6mAU$602k

-AU$41m

Mar 31 2024n/an/a

-AU$30m

Dec 31 2023n/an/a

-AU$19m

Sep 30 2023n/an/a

-AU$12m

Jun 30 2023AU$2mAU$576k

-AU$6m

Mar 31 2023n/an/a

-AU$4m

Dec 31 2022n/an/a

-AU$2m

Sep 30 2022n/an/a

-AU$7m

Jun 30 2022AU$2mAU$547k

-AU$12m

Mar 31 2022n/an/a

-AU$16m

Dec 31 2021n/an/a

-AU$19m

Sep 30 2021n/an/a

-AU$16m

Jun 30 2021AU$1mAU$351k

-AU$13m

Compensation vs Market: Brent's total compensation ($USD3.83M) is above average for companies of similar size in the Australian market ($USD283.99K).

Compensation vs Earnings: Brent's compensation has increased whilst the company is unprofitable.

CEO

Brent MacGregor (60 yo)

4.2yrs

Tenure

AU$6,166,500

Compensation

Mr. Brent MacGregor serves as an Independent Director at Dynavax Technologies Corporation since July 2020. He has been the Chief Executive Officer of Medical Developments International Limited since Novemb...

Leadership Team

NamePositionTenureCompensationOwnership
Brent MacGregor
Chief Executive Officer4.2yrsAU$6.17m0.20%
A$ 96.2k
Anita James
Chief Financial Officer2.7yrsAU$5.94m0.056%
A$ 26.8k
Anastasia Tan
Head of Operations & Supply Chainno datano datano data
Scott Courtney
Chief Scientific Officer5.5yrsno datano data
Tara Eaton
General Counsel & Company Secretary2.4yrsno datano data
Anthony Wheal
Head of People & Cultureno datano datano data
Wayne Pearce
Head of Production4.5yrsno datano data
Stefaan Schatteman
Head of Europe4.4yrsno datano data
Julianne Alexander
Head of Medical Affairs & Clinical Developmentno datano datano data
Jas Singh
Global Head of Respiratoryno datano datano data
Damian Meagher
Head of Quality & Regulatory Affairsno datano datano data
Sue Yee
Acting Head of Medical Affairs & Clinical Developmentno datano datano data

4.3yrs

Average Tenure

Experienced Management: MVP's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gordon Naylor
Non-Executive Chairman4.3yrsAU$95.00k0.84%
A$ 404.0k
Russell Basser
Non-Executive Director1.3yrsAU$50.00k0.014%
A$ 6.7k
Leon Hoare
Non-Executive Director11.3yrsAU$60.00k0.055%
A$ 26.4k
Richard Betts
Non-Executive Director3.7yrsAU$60.00k0.021%
A$ 9.9k
Christine Emmanuel-Donnelly
Non-Executive Director4.7yrsAU$60.00k0.080%
A$ 38.5k

4.3yrs

Average Tenure

Experienced Board: MVP's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 14:57
End of Day Share Price 2025/01/03 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medical Developments International Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dennis HulmeAPP Securities Pty Ltd.
Anubhav SaxenaBell Potter
Martyn JacobsCanaccord Genuity